Yeast two-hybrid screening service  Sign up for PNAS Online eTocs
Link: Info for AuthorsLink: Editorial BoardLink: AboutLink: SubscribeLink: AdvertiseLink: ContactLink: Sitemap Link: PNAS Home
Proceedings of the National Academy of Sciences
Link: Current Issue "" Link: Archives "" Link: Online Submission ""  Link: Advanced Search

Published online on August 22, 2003, 10.1073/pnas.1734137100
PNAS | September 2, 2003 | vol. 100 | no. 18 | 10429-10434


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohira, T.
Right arrow Articles by Drabkin, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohira, T.
Right arrow Articles by Drabkin, H. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg  
What's this?

 Previous Article  | Table of Contents |  Next Article 

Medical Sciences
WNT7a induces E-cadherin in lung cancer cells

Tatsuo Ohira *, Robert M. Gemmill *, Kevin Ferguson *, Sophie Kusy {dagger}, Joëlle Roche {dagger}, Elisabeth Brambilla {ddagger}, Chan Zeng §, Anna Baron §, Lynne Bemis *, Paul Erickson *, Elizabeth Wilder ¶, Anil Rustgi ||, Jan Kitajewski **, Edward Gabrielson {dagger}{dagger}, Roy Bremnes {ddagger}{ddagger}, Wilbur Franklin {ddagger}{ddagger}, and Harry A. Drabkin * §§

*Division of Medical Oncology, Departments of §Biometrics/Preventive Medicine and {ddagger}{ddagger}Pathology, University of Colorado Health Sciences and Cancer Centers, 4200 East 9th Avenue, Denver, CO 80262; {dagger}Institut de Biologie Moléculaire et d'Ingénierie Génétique, EA 2224, Université de Poitiers, 40 Avenue du Recteur Pineau, 86022 Poitiers Cédex, France; {ddagger}Laboratoire de Pathologie Cellulaire, Institut National de la Santé et de la Recherche Médicale 9924, Centre Hospitalo-Universitaire Albert Michallon, F-38043 Grenoble, France; Department of Cell and Developmental Biology and ||Division of Gastroenterology, Department of Genetics, and Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104-6100; **Department of Pathology and Center for Reproductive Sciences, Columbia University College of Physicians and Surgeons, New York, NY 10032; and {dagger}{dagger}Department of Pathology, Johns Hopkins Medical Center, Baltimore, MD 21231

Communicated by David M. Prescott, University of Colorado, Boulder, CO, July 3, 2003 (received for review April 9, 2003)

E-cadherin loss in cancer is associated with de-differentiation, invasion, and metastasis. Drosophila DE-cadherin is regulated by Wnt/{beta}-catenin signaling, although this has not been demonstrated in mammalian cells. We previously reported that expression of WNT7a, encoded on 3p25, was frequently downregulated in lung cancer, and that loss of E-cadherin or {beta}-catenin was a poor prognostic feature. Here we show that WNT7a both activates E-cadherin expression via a {beta}-catenin specific mechanism in lung cancer cells and is involved in a positive feedback loop. Li+, a GSK3{beta} inhibitor, led to E-cadherin induction in an inositol-independent manner. Similarly, exposure to mWNT7a specifically induced free {beta}-catenin and E-cadherin. Among known transcriptional suppressors of E-cadherin, ZEB1 was uniquely correlated with E-cadherin loss in lung cancer cell lines, and its inhibition by RNA interference resulted in E-cadherin induction. Pharmacologic reversal of E-cadherin and WNT7a losses was achieved with Li+, histone deacetylase inhibition, or in some cases only with combined inhibitors. Our findings provide support that E-cadherin induction by WNT/{beta}-catenin signaling is an evolutionarily conserved pathway operative in lung cancer cells, and that loss of WNT7a expression may be important in lung cancer development or progression by its effects on E-cadherin.


Abbreviations: NSCLC, non-small-cell lung cancer; TSA, trichostatin A; Ct values, cycle threshold values; IMPase, inositol monophosphatase; HDAC, histone deacetylase; siRNA, small interfering RNA.

§§ To whom correspondence should be addressed. E-mail: harry.drabkin{at}uchsc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg    What's this?


This article has been cited by other articles in HighWire Press-hosted journals:


Home page
Cancer Res.Home page
T. R. Graham, H. E. Zhau, V. A. Odero-Marah, A. O. Osunkoya, K. S. Kimbro, M. Tighiouart, T. Liu, J. W. Simons, and R. M. O'Regan
Insulin-like Growth Factor-I-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
Cancer Res., April 1, 2008; 68(7): 2479 - 2488.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Yang, J. M. Amann, T. Kikuchi, R. Porta, M. Guix, A. Gonzalez, K.-H. Park, D. Billheimer, C. L. Arteaga, H.-H. Tai, et al.
Inhibition of Epidermal Growth Factor Receptor Signaling Elevates 15-Hydroxyprostaglandin Dehydrogenase in Non-Small-Cell Lung Cancer
Cancer Res., June 15, 2007; 67(12): 5587 - 5593.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. A. Frederick, B. A. Helfrich, C. D. Coldren, D. Zheng, D. Chan, P. A. Bunn Jr., and D. Raben
Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma
Mol. Cancer Ther., June 1, 2007; 6(6): 1683 - 1691.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Fujii, L. You, Z. Xu, K. Uematsu, J. Shan, B. He, I. Mikami, L. R. Edmondson, G. Neale, J. Zheng, et al.
An Antagonist of Dishevelled Protein-Protein Interaction Suppresses {beta}-Catenin-Dependent Tumor Cell Growth
Cancer Res., January 15, 2007; 67(2): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Dohadwala, S.-C. Yang, J. Luo, S. Sharma, R. K. Batra, M. Huang, Y. Lin, L. Goodglick, K. Krysan, M. C. Fishbein, et al.
Cyclooxygenase-2-Dependent Regulation of E-Cadherin: Prostaglandin E2 Induces Transcriptional Repressors ZEB1 and Snail in Non-Small Cell Lung Cancer.
Cancer Res., May 15, 2006; 66(10): 5338 - 5345.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. S. Spoelstra, N. G. Manning, Y. Higashi, D. Darling, M. Singh, K. R. Shroyer, R. R. Broaddus, K. B. Horwitz, and J. K. Richer
The Transcription Factor ZEB1 Is Aberrantly Expressed in Aggressive Uterine Cancers.
Cancer Res., April 1, 2006; 66(7): 3893 - 3902.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. E. Witta, R. M. Gemmill, F. R. Hirsch, C. D. Coldren, K. Hedman, L. Ravdel, B. Helfrich, R. Dziadziuszko, D. C. Chan, M. Sugita, et al.
Restoring E-Cadherin Expression Increases Sensitivity to Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cell Lines
Cancer Res., January 15, 2006; 66(2): 944 - 950.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. L. Yauch, T. Januario, D. A. Eberhard, G. Cavet, W. Zhu, L. Fu, T. Q. Pham, R. Soriano, J. Stinson, S. Seshagiri, et al.
Epithelial versus Mesenchymal Phenotype Determines In vitro Sensitivity and Predicts Clinical Activity of Erlotinib in Lung Cancer Patients
Clin. Cancer Res., December 15, 2005; 11(24): 8686 - 8698.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Thomson, E. Buck, F. Petti, G. Griffin, E. Brown, N. Ramnarine, K. K. Iwata, N. Gibson, and J. D. Haley
Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non-Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition
Cancer Res., October 15, 2005; 65(20): 9455 - 9462.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J. Li, J. V. Zhang, Y.-J. Cao, J.-X. Zhou, W.-M. Liu, X.-J. Fan, and E.-K. Duan
Inhibition of the Beta-Catenin Signaling Pathway in Blastocyst and Uterus During the Window of Implantation in Mice
Biol Reprod, March 1, 2005; 72(3): 700 - 706.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Garnis, J. Campbell, J. J. Davies, C. MacAulay, S. Lam, and W. L. Lam
Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis
Hum. Mol. Genet., February 15, 2005; 14(4): 475 - 482.
[Abstract] [Full Text] [PDF]